Form SC 13D ATHENAHEALTH INC Filed by: ELLIOTT ASSOCIATES, L.P.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Athenahealth (ATHN) 'Looks Forward' to Discussions with Elliot Management as Shares Surge
May 18, 2017 1:20 PM EDTAthenahealth (NASDAQ: ATHN) said it was aware of Elliot's Management new stake in the company and looks forward to discussing the firm views and the company's actions being taken to enhance shareholder value.
"We are aware of Elliots filing and... More
athenahealth (ATHN) PT Raised to $147 at Evercore ISI Following Elliott 13D
May 18, 2017 10:45 AM EDTEvercore ISI raised its price target on athenahealth (NASDAQ: ATHN) to $147.00 (from $118.00) while maintaining a Outperform rating following the Elliott Associates 13D.
Analyst Ross Muken said while the filing surprised many, it is not altogether shocking that a relatively underperforming, though strategically well-placed... More
UPDATE: Elliott Associates Reports New 9.3% Stake in Athenahealth (ATHN) - 13D
May 18, 2017 8:38 AM EDT(Updated - May 18, 2017 8:42 AM EDT)
In a 13D filing, Elliott Associates reports new 9.2% stake in Athenahealth (NASDAQ: ATHN). Elliott called the share significantly undervalued and represent an attractive investment opportunity. Elliott believe the Issuer operates in a highly strategic area at the intersection of technology and healthcare with a disruptive value proposition, a leading competitive position and a compelling product set, the value of which is not reflected in the Issuer's current market value. Elliott believe that there are numerous operational and strategic opportunities to maximize shareholder value and the... More
